Abstract
Introduction

More than 70 million diagnostic radiographic examinations using iodinated contrast media (ICM) are performed worldwide each year (1). Anaphylactoid reactions to ICM are one of the common complications during these examinations. Clinical manifestations of systemic anaphylaxis include various combinations of flushing, urticaria laryngeal edema, and hypotension. The incidence of a severe reaction such as shock is extremely low (less than one death per 100,000 patients) (2-7). However, ICM-related adverse reactions should be prevented and appropriately treated when they do occur. This is our first report of successful percutaneous coronary intervention (PCI) without the use of ICM in a patient with unstable angina and prior systemic anaphylaxis to ICM.
Case Report
A
F i g u r e 2 . ( A) T h e s e c o n d wi r e wa s a d v a n c e d i n t o t h e r i g h t v e n t r i c u l a r b r a n c h ( a r r o ws ) , wh i c h wa s l o c a t e d a r o u n d t h e s e c o n d s t e n o s i s a t t h e mi d p o r t i o n o f RCA. T h i s wi r e wa s u s e d a s o n e o f t h e ma r k e r s f o r s t e n t i n g . ( B ) A T a x u s E x p r e s s T M S t e n t ( P E S ) wa s i mp l a n t e d u n d e r t h e g u i d a n c e o f t h e I VUS a n d t h e s e c o n d wi r e . T h e s e c o n d wi r e wa s r e mo v e d c a r e f u l l y j u s t b e f o r e t h e s t e n t d i l a t i o n .
F i g u r e 3 . I n t r a c o r o n a r y u l t r a s o u n d ( I VUS ) i ma g i n g : ( Up p e r : l o n g i t u d i n a l v i e w, L o we r : a x i a l v i e w) . ( A) P r e -p r o c e d u r a l I VUS r e v e a l e d t wo s t e n o t i c l e s i o n s , l o c a t e d a t t h e p r o x i ma l ( c i r c l e o f a s o l i d l i n e ) a n d t h e mi d d l e ( c i r c l e o f a d o t t e d l i n e ) p o r t i o n o f r i g h t c o r o n a r y a r t e r y . ( B ) P o s t -p r o c ed u r a l I VUS i ma g e d e mo n s t r a t e d t h e o p t i ma l r e s u l t s .
. In addition, ephedrine, which is used as a bronchodilator of the β2 receptor stimulant, has been sometimes added in a few clinical trials (8) . However, the addition of ephedrine to decrease the prevalence of adverse reactions to ICM has not gained wide acceptance. Ephedrine is contraindicated for uncontrollable hypertension and unstable angina because it also releases norepinephrine from sympathetic nerve endings, which makes α-and β1-adrenergic stimulants activate (10) 
